Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs-Reference-Cited by-同舟云学术

Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs

Published:2014-07-31 Issue:2 Volume:38 Page:160-168
ISSN:0140-7783
Container-title:Journal of Veterinary Pharmacology and Therapeutics
language:en
Short-container-title:J. vet. Pharmacol. Therap.

Author:

Tipold A.¹²,Keefe T. J.³,Löscher W.²⁴,Rundfeldt C.⁵,Vries F.⁶

Affiliation:

1. Department of Small Animal Medicine and Surgery University of Veterinary Medicine Hannover Germany

2. Center for Systems Neuroscience Hannover Germany

3. Department of Environmental & Radiological Health Sciences College of Veterinary Medicine & Biomedical Sciences Colorado State University Fort Collins CO USA

4. Department of Pharmacology, Toxicology and Pharmacy University of Veterinary Medicine Hannover Hannover Germany

5. Drug Consulting Network Coswig Germany

6. Boehringer Ingelheim Vetmedica GmbH Ingelheim am Rhein Germany

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

General Veterinary,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvp.12151

Reference41 articles.

1. Premature Death, Risk Factors, and Life Patterns in Dogs with Epilepsy

2. Predictive Performance of Renal Function Equations for Patients with Chronic Kidney Disease and Normal Serum Creatinine Levels

3. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985–1989);Dayrell‐Hart B.;Journal of the American Veterinary Medical Association,1991

4. European Agency for the Evaluation of Medicinal Products (EMEA)(2004).Guideline on procedures for competent authorities for pharmacovigilance information for veterinary medicinal products. Committee for Veterinary Medicinal Products (CVMP). EMEA/CVMP/345/98‐Rev. 1‐FINAL.http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004997.pdf

5. European Medicines Agency(2011).Combined VeDDRA list of clinical terms for reporting suspected adverse reactions in animals and humans to veterinary medicinal products. EMA/CVMP/10418/2009‐Rev.3.http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/07/WC500094802.pdf

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Findings on the Crystal Polymorphism of Imepitoin;Molecules;2024-04-11

2. Pilot Study on the Efficacy and Safety of Long-Term Oral Imepitoin Treatment for Control of (Thunder)Storm-Associated Noise Phobia/Noise Aversion in Dogs Using an Individualized-Dose Titration Approach;Animals;2024-02-06

3. Epilepsy is more than a simple seizure disorder: Parallels between human and canine cognitive and behavioural comorbidities;The Veterinary Journal;2024-02

4. Remarkable anecdotes illustrating the nature and effect of seizure-precipitating factors in Border Collies with idiopathic epilepsy;Frontiers in Veterinary Science;2023-09-14

5. Comparison of caregivers’ assessments of clinical outcome in dogs with idiopathic epilepsy administered levetiracetam, zonisamide, or phenobarbital monotherapy;Journal of the American Veterinary Medical Association;2023-03-23